"Clostridium tetani" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The cause of TETANUS in humans and domestic animals. It is a common inhabitant of human and horse intestines as well as soil. Two components make up its potent exotoxin activity, a neurotoxin and a hemolytic toxin.
| Descriptor ID |
D003017
|
| MeSH Number(s) |
B03.300.390.400.200.725 B03.353.625.375.500.725 B03.510.415.400.200.725
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clostridium tetani".
Below are MeSH descriptors whose meaning is more specific than "Clostridium tetani".
This graph shows the total number of publications written about "Clostridium tetani" by people in this website by year, and whether "Clostridium tetani" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Clostridium tetani" by people in Profiles.
-
Does tetanus vaccination contribute to reduced severity of the COVID-19 infection? Med Hypotheses. 2021 Jan; 146:110395.
-
SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis). Med Hypotheses. 2020 Aug; 141:109779.
-
Tetanus presenting primarily as periocular discomfort in a patient who underwent surgery for sleep apnea: A case report and brief literature review. Medicine (Baltimore). 2019 Jun; 98(23):e15652.
-
Serum anti-tetanus and measles antibody titres in Ugandan children aged 4 months to 6 years: implications for vaccine programme. Epidemiol Infect. 2018 07; 146(9):1151-1156.
-
Clostridium tetani bacteremia in a patient with cirrhosis following transarterial chemoembolization treatment for hepatocellular carcinoma. J Microbiol Immunol Infect. 2018 Feb; 51(1):155-156.